Name That Brand: December 2012

Can you name the brand? Each month we print part of a popular pharmaceutical product or advertisement, with clues to its identity. Readers are invited to name the brand for a chance to win a copy of Medicine Avenue II. E-mail your answer to NameThatBrand@haymarketmedia.com or fax 646-638-6150. The deadline is December 31, 2012. The winner will be picked randomly from all correct entries.

Brand X gives an old name a new spin
An alternate title for this picture could be “Do you remember me?” This OTC medication has been gone for a while, and although nothing may have taken its place on drugstore shelves, the drug maker is taking no chances, pairing its revival with a condition-awareness campaign and a handheld app that helps patients track symptom triggers and lets them send this info to physicians between or even before appointments.

OCTOBER'S WINNER...
Sandy Buck, Group Copy Supervisor at The Access Group, correctly identified an ad for Juvéderm XC, Allergan's gel filler used to smooth away wrinkles around the mouth and nose.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.